MIREN
ZULAICA IJURCO
Investigadora hasta 2022
![Foto de MIREN](/img/nophoto.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (23)
2023
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow-up study
European Journal of Neurology, Vol. 30, Núm. 1, pp. 215-223
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
Senescence plays a role in myotonic dystrophy type 1
JCI insight, Vol. 7, Núm. 19
-
White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study
Scientific reports, Vol. 12, Núm. 1, pp. 3988
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Description of Two Families with New Mutations in Familial Cerebral Cavernous Malformations Genes
Journal of Stroke and Cerebrovascular Diseases, Vol. 30, Núm. 12
2020
-
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262
-
A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 1, pp. 105-111
-
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study
Journal of Neuropsychology, Vol. 14, Núm. 1, pp. 121-134
-
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease
Aging, Vol. 12, Núm. 17, pp. 16690-16708
-
Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1802-1815
-
Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study
European Journal of Neurology, Vol. 27, Núm. 8, pp. 1364-1373
-
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
Genetics in Medicine, Vol. 22, Núm. 9, pp. 1478-1488
-
Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain
Genes, Vol. 11, Núm. 5
2019
-
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 50, pp. 25203-25213
-
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
Movement Disorders, Vol. 34, Núm. 10, pp. 1547-1561
-
Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
NeuroImage: Clinical, Vol. 24
-
Reply to: “Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion”
Movement Disorders
2018
-
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
Frontiers in Aging Neuroscience, Vol. 10